Roflumilast is a medication that belongs to a class of drugs known as phosphodiesterase-4 (PDE4) inhibitors. It is commonly used in the treatment of severe chronic obstructive pulmonary disease (COPD) to reduce inflammation in the lungs and improve breathing.

This medication works by targeting specific enzymes in the body that are involved in the inflammatory response. By inhibiting these enzymes, roflumilast helps to decrease inflammation in the airways, making it easier for individuals with COPD to breathe.

Roflumilast is typically prescribed for patients who have severe COPD and frequent exacerbations, despite using other medications such as bronchodilators or inhaled corticosteroids. It is important to note that roflumilast is not a rescue medication and should not be used to treat sudden breathing problems or acute exacerbations of COPD.

As with any medication, roflumilast may cause side effects in some individuals. Common side effects of roflumilast include diarrhea, nausea, weight loss, and headache. It is important to discuss any concerns or side effects with your healthcare provider.

It is crucial to follow your healthcare provider’s instructions when taking roflumilast, including the recommended dosage and frequency of administration. It is also important to continue using other COPD medications as prescribed by your healthcare provider.

Overall, roflumilast can be an effective treatment option for individuals with severe COPD who have not responded well to other medications. If you have any questions or concerns about roflumilast or its use in your treatment plan, do not hesitate to speak with your healthcare provider.